APA (7th ed.) Citation

DA, C., J, H., J, G., M, T., M, S., E, D., . . . H, M. (2010). Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection. The Journal of infectious diseases, 201(6), 803. https://doi.org/10.1086/650697

Chicago Style (17th ed.) Citation

DA, Cooper, et al. "Maraviroc Versus Efavirenz, Both in Combination with Zidovudine-lamivudine, for the Treatment of Antiretroviral-naive Subjects with CCR5-tropic HIV-1 Infection." The Journal of Infectious Diseases 201, no. 6 (2010): 803. https://doi.org/10.1086/650697.

MLA (9th ed.) Citation

DA, Cooper, et al. "Maraviroc Versus Efavirenz, Both in Combination with Zidovudine-lamivudine, for the Treatment of Antiretroviral-naive Subjects with CCR5-tropic HIV-1 Infection." The Journal of Infectious Diseases, vol. 201, no. 6, 2010, p. 803, https://doi.org/10.1086/650697.